Gene Therapy Market

The gene therapy market involves modifying or replacing a patient's unhealthy genes to treat or prevent diseases. The primary customers are patients with genetic disorders, served by biopharmaceutical companies and healthcare systems. Key growth drivers include the increasing prevalence of genetic disorders, significant advancements in gene-editing technologies like CRISPR-Cas9, and streamlined regulatory approval processes from bodies like the FDA and EMA.